Cargando…

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer

Radiomics is an image analysis approach for extracting large amounts of quantitative information from medical images using a variety of computational methods. Our goal was to evaluate the utility of radiomic feature analysis from (18)F-fluorothymidine positron emission tomography (FLT PET) obtained...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulrich, Ethan J., Menda, Yusuf, Boles Ponto, Laura L., Anderson, Carryn M., Smith, Brian J., Sunderland, John J., Graham, Michael M., Buatti, John M., Beichel, Reinhard R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Grapho Publications, LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403029/
https://www.ncbi.nlm.nih.gov/pubmed/30854454
http://dx.doi.org/10.18383/j.tom.2018.00038
_version_ 1783400494485471232
author Ulrich, Ethan J.
Menda, Yusuf
Boles Ponto, Laura L.
Anderson, Carryn M.
Smith, Brian J.
Sunderland, John J.
Graham, Michael M.
Buatti, John M.
Beichel, Reinhard R.
author_facet Ulrich, Ethan J.
Menda, Yusuf
Boles Ponto, Laura L.
Anderson, Carryn M.
Smith, Brian J.
Sunderland, John J.
Graham, Michael M.
Buatti, John M.
Beichel, Reinhard R.
author_sort Ulrich, Ethan J.
collection PubMed
description Radiomics is an image analysis approach for extracting large amounts of quantitative information from medical images using a variety of computational methods. Our goal was to evaluate the utility of radiomic feature analysis from (18)F-fluorothymidine positron emission tomography (FLT PET) obtained at baseline in prediction of treatment response in patients with head and neck cancer. Thirty patients with advanced-stage oropharyngeal or laryngeal cancer, treated with definitive chemoradiation therapy, underwent FLT PET imaging before treatment. In total, 377 radiomic features of FLT uptake and feature variants were extracted from volumes of interest; these features variants were defined by either the primary tumor or the total lesion burden, which consisted of the primary tumor and all FLT-avid nodes. Feature variants included normalized measurements of uptake, which were calculated by dividing lesion uptake values by the mean uptake value in the bone marrow. Feature reduction was performed using clustering to remove redundancy, leaving 172 representative features. Effects of these features on progression-free survival were modeled with Cox regression and P-values corrected for multiple comparisons. In total, 9 features were considered significant. Our results suggest that smaller, more homogenous lesions at baseline were associated with better prognosis. In addition, features extracted from total lesion burden had a higher concordance index than primary tumor features for 8 of the 9 significant features. Furthermore, total lesion burden features showed lower interobserver variability.
format Online
Article
Text
id pubmed-6403029
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Grapho Publications, LLC
record_format MEDLINE/PubMed
spelling pubmed-64030292019-03-08 FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer Ulrich, Ethan J. Menda, Yusuf Boles Ponto, Laura L. Anderson, Carryn M. Smith, Brian J. Sunderland, John J. Graham, Michael M. Buatti, John M. Beichel, Reinhard R. Tomography Research Articles Radiomics is an image analysis approach for extracting large amounts of quantitative information from medical images using a variety of computational methods. Our goal was to evaluate the utility of radiomic feature analysis from (18)F-fluorothymidine positron emission tomography (FLT PET) obtained at baseline in prediction of treatment response in patients with head and neck cancer. Thirty patients with advanced-stage oropharyngeal or laryngeal cancer, treated with definitive chemoradiation therapy, underwent FLT PET imaging before treatment. In total, 377 radiomic features of FLT uptake and feature variants were extracted from volumes of interest; these features variants were defined by either the primary tumor or the total lesion burden, which consisted of the primary tumor and all FLT-avid nodes. Feature variants included normalized measurements of uptake, which were calculated by dividing lesion uptake values by the mean uptake value in the bone marrow. Feature reduction was performed using clustering to remove redundancy, leaving 172 representative features. Effects of these features on progression-free survival were modeled with Cox regression and P-values corrected for multiple comparisons. In total, 9 features were considered significant. Our results suggest that smaller, more homogenous lesions at baseline were associated with better prognosis. In addition, features extracted from total lesion burden had a higher concordance index than primary tumor features for 8 of the 9 significant features. Furthermore, total lesion burden features showed lower interobserver variability. Grapho Publications, LLC 2019-03 /pmc/articles/PMC6403029/ /pubmed/30854454 http://dx.doi.org/10.18383/j.tom.2018.00038 Text en © 2019 The Authors. Published by Grapho Publications, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Articles
Ulrich, Ethan J.
Menda, Yusuf
Boles Ponto, Laura L.
Anderson, Carryn M.
Smith, Brian J.
Sunderland, John J.
Graham, Michael M.
Buatti, John M.
Beichel, Reinhard R.
FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
title FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
title_full FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
title_fullStr FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
title_full_unstemmed FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
title_short FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
title_sort flt pet radiomics for response prediction to chemoradiation therapy in head and neck squamous cell cancer
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403029/
https://www.ncbi.nlm.nih.gov/pubmed/30854454
http://dx.doi.org/10.18383/j.tom.2018.00038
work_keys_str_mv AT ulrichethanj fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT mendayusuf fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT bolespontolaural fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT andersoncarrynm fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT smithbrianj fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT sunderlandjohnj fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT grahammichaelm fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT buattijohnm fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer
AT beichelreinhardr fltpetradiomicsforresponsepredictiontochemoradiationtherapyinheadandnecksquamouscellcancer